MedPath

Menatetrenone

Generic Name
Menatetrenone
Drug Type
Small Molecule
Chemical Formula
C31H40O2
CAS Number
863-61-6
Unique Ingredient Identifier
27Y876D139

Overview

Menatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma.

Background

Menatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma.

Indication

适用于骨质疏松症的骨量和疼痛的改善。

Associated Conditions

  • Osteoporosis

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

Product Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

HSA Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval Number

No HSA products found

No HSA products found for this drug

NMPA Approved Products

Product Name
Approval Number
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import
国药准字HJ20150115
胶囊剂
固力康
15mg
Chemical Drug
Approved
2024/05/22
Import
国药准字HJ20150114
胶囊剂
固力康
15mg
Chemical Drug
Approved
2024/05/22
Import
国药准字H20253282
胶囊剂
N/A
15mg
Chemical Drug
Approved
2025/01/24
Domestic
国药准字J20150113
胶囊剂
固力康
15mg
Chemical Drug
Approved
2020/04/01
Import
H20150114
胶囊剂
固力康
15mg
Chemical Drug
Expired
2019/09/17
Import
H20150115
胶囊剂
固力康
15mg
Chemical Drug
Expired
2019/09/17
Import

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Registration Date

No PPB products found

No PPB products found for this drug

TGA Approved Products

Product Name
ARTG ID
Sponsor
Status
Registration Date
Ingredient

No TGA products found

No TGA products found for this drug

© Copyright 2025. All Rights Reserved by MedPath